Journal of International Oncology››2024,Vol. 51››Issue (10): 670-672.doi:10.3760/cma.j.cn371439-20240429-00113
Received:2024-04-29Revised:2024-08-14Online:2024-10-08Published:2024-12-04
"
"
"
| [1] | Makino H, Nishio S, Tsubamoto H, et al. Treatment and prognosis of bone metastasis from cervical cancer (KCOG-G1202s)[J].J Obstet Gynaecol Res,2016,2(6): 701-706. DOI:10.1111/jog.12956. |
| [2] | Ferrandina G, Salutari V, Testa A, et al. Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature[J].BMC Cancer,2006,6: 169.DOI:10.1186/1471-2407-6-169. pmid:16800899 |
| [3] | Williams JB, Youngberg RA, Bui-Mansfield LT, et al. MR imaging of skeletal muscle metastases[J].AJR Am J Roentgenol,1997,168(2): 555-557.DOI:10.2214/ajr.168.2.9016246. |
| [4] | Agarwal U, Dahiya P, Chauhan A, et al. Scalp metastasis in carcinoma of the uterine cervix—a rare entity[J].Gynecol Oncol,2002,87(3): 310-312. DOI:10.1006/gyno.2002.6829. pmid:12468331 |
| [5] | Takagi H, Miura S, Matsunami K, et al. Cervical cancer metastasis to the scalp: case report and literature review[J].Eur J Gynaecol Oncol,2010,31(2): 217-218. pmid:20527246 |
| [6] | Uhrinak AN, Tierney KE, Duncun KL, et al. Intraocular metastasis from primary cervical cancer: a case report and review of the literature[J].Gynecol Oncol Rep,2015,12: 61-63. DOI:10.1016/j.gore.2015.03.003. |
| [7] | 王成双, 宋梅, 邹鹏程, 等. 宫颈癌鼻转移1例报告并文献复习[J].安徽医药,2021,25(10): 2085-2087. DOI:10.3969/j.issn.1009-6469.2021.10.041. |
| [8] | 彭海艳, 邱惠, 梅自洁, 等. 宫颈癌胸膜转移一例[J].国际肿瘤学杂志,2020,47(7): 446-448. DOI:10.3760/cma.j.cn371439-20200304-00055. |
| [9] | 周文彪, 徐洁, 蒋小芹, 等. 子宫颈癌胃转移一例报告并文献复习[J].中华肿瘤防治杂志,2019,26(23): 1814-1817. DOI:10.16073/j.cnki.cjcpt.2019.23.13. |
| [10] | 冯铭彬, 刘秦, 陈可盈, 等. 宫颈癌胆囊转移1例报道[J].岭南现代临床外科,2023,23(5): 424-426. DOI:10.3969/j.issn.1009-976X.2023.05.010. |
| [11] | 李帅, 王娟, 夏仕雪, 等. 子宫颈混合性腺神经内分泌癌胰腺转移1例[J].中国医学影像学杂志,2022,30(12): 1283-1284. DOI:10.3969/j.issn.1005-5185.2022.12.016. |
| [12] | 刘美君, 肖雪, 姚远. 疑难宫颈鳞状细胞癌卵巢转移一例[J].国际肿瘤学杂志,2020,47(2): 127-128. DOI:10.3760/cma.j.issn.1673-422X.2020.02.014. |
| [13] | 朱莉, 敖锋. 罕见宫颈癌转移至腰大肌1例[J].湖北医药学院学报,2020,39(6): 614-615, 651. DOI:10.13819/j.issn.2096-708X.2020.06.020. |
| [14] | Ciccone MA, Conturie CL, Lee CM, et al. Toe metastasis: a rare pattern of cervical cancer spread[J].Gynecol Oncol Case Rep,2014,8: 7-9. DOI:10.1016/j.gynor.2013.12.004. |
| [15] | 罗家伦, 徐慧琴, 汪会, 等. 肌肉转移癌的18F-FDG PET/CT影像表现及临床特征研究[J].安徽医科大学学报,2019,54(5): 753-758. DOI:10.19405/j.cnki.issn1000-1492.2019.05.019. |
| [16] | 沈晓燕, 崔恒. 复发性和转移性子宫颈癌化疗的研究进展[J].中华妇产科杂志,2013,48(10): 788-791. DOI:10.3760/cma.j.issn.0529-567x.2013.10.016. |
| [17] | 中国临床肿瘤学会指南工作委员会.肿瘤临床肿瘤学会(CSCO)宫颈癌诊疗指南2023[M]. 北京: 人民卫生出版社,2023. |
| [18] | Colombo N, Dubot C, Lorusso D, et al. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer[J].N Engl J Med,2021,385(20): 1856-1867. DOI:10.1056/NEJMoa2112435. |
| [19] | 周晖, 刘昀昀, 罗铭, 等. 《2022 NCCN子宫颈癌临床实践指南(第1版)》解读[J].中国实用妇科与产科杂志,2021,37(12): 1220-1226. DOI:10.19538/j.fk2021120112. |
| [20] | Chung HC, Ros W, Delord JP, et al. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase Ⅱ KEYNOTE -158 study[J].J Clin Oncol,2019,37(17): 1470-1478. DOI:10.1200/JCO.18.01265. |
| [21] | Wang G, Liu Y, He F. Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI[J].Nuklearmedizin,2016,55(5): N46-N48. pmid:27668300 |
| [22] | Liu F, Zhang Q, Zhou D, et al. Effectiveness of18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies[J].BMC Cancer,2019,19(1): 323. DOI:10.1186/s12885-019-5488-5. |
| [23] | 江涛, 李隆玉, 潘玫, 等. p16在宫颈癌组织中的表达及其意义[J].实用癌症杂志,2005,20(6): 581-583, 587. DOI:10.3969/j.issn.1001-5930.2005.06.007. |
| [24] | Lin Z, Nan Y, Zhang X, et al. Reverse transcription-polymerase chain reaction and western blotting analysis for detection of p63 isoforms in uterine cervical cancers[J].Int J Gynecol Cancer,2006,16(4): 1643-1647. DOI:10.1111/j.1525-1438.2006.00638.x. pmid:16884378 |
| [25] | Tewari KS, Sill MW, Penson RT, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)[J].Lancet,2017,390(10103): 1654-1663. DOI:10.1016/S0140-6736(17)31607-0. pmid:28756902 |
| [26] | Coleman RL, Lorusso D, Gennigens C, et al. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204 /GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study[J].Lancet Oncol,2021,22(10): 609-619. DOI:10.1016/S1470-2045(21)00056-5. |
| [27] | 国家药品监督管理局. 国家药监局附条件批准卡度尼利单抗注射液上市[EB/OL]. (2022-06-29)[2024-04-20]. https://www.nmpa.gov.cn/zhuanti/cxylqx/cxypxx/20220629135936153.html. |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
